Nurix Therapeutics, Inc. financial data

Symbol
NRIX on Nasdaq
Industry
Pharmaceutical Preparations
Location
1700 Owens Street, Suite 205, San Francisco, CA
State of incorporation
DE
Fiscal year end
November 30
Former names
Nurix, Inc. (to 9/18/2015)
Latest financial report
10-Q - Q1 2025 - Apr 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 592 % +65.3%
Debt-to-equity 31.5 % -41.4%
Return On Equity -47.5 % +29.2%
Return On Assets -36.1 % +17.2%
Operating Margin -195 % +55.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 76.2M shares +55.1%
Common Stock, Shares, Outstanding 76.2M shares +55.1%
Entity Public Float 996M USD +112%
Common Stock, Value, Issued 76K USD +55.1%
Weighted Average Number of Shares Outstanding, Basic 83.6M shares +52.2%
Weighted Average Number of Shares Outstanding, Diluted 83.6M shares +52.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 80.9M USD +94%
Revenue from Contract with Customer, Excluding Assessed Tax 56.4M USD +11.3%
Research and Development Expense 241M USD +24.8%
General and Administrative Expense 45.8M USD +2.05%
Operating Income (Loss) -231M USD -46.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -208M USD -44%
Income Tax Expense (Benefit) 180K USD +100%
Net Income (Loss) Attributable to Parent -208M USD -44%
Earnings Per Share, Basic -2.79 USD/shares -4.89%
Earnings Per Share, Diluted -2.79 USD/shares -4.89%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 75.9M USD +52.4%
Marketable Securities, Current 217M USD -27.1%
Cash, Cash Equivalents, and Short-term Investments 550M USD +125%
Accounts Receivable, after Allowance for Credit Loss, Current 2M USD
Assets, Current 564M USD +125%
Property, Plant and Equipment, Net 18.4M USD +3.23%
Operating Lease, Right-of-Use Asset 26.4M USD -10%
Other Assets, Noncurrent 5.63M USD +68.4%
Assets 615M USD +96.7%
Accounts Payable, Current 8.4M USD +41.9%
Employee-related Liabilities, Current 19.9M USD +18.7%
Contract with Customer, Liability, Current 30.6M USD -33.6%
Liabilities, Current 90M USD +2.7%
Contract with Customer, Liability, Noncurrent 24.2M USD -29.9%
Operating Lease, Liability, Noncurrent 20M USD -8.52%
Liabilities 134M USD -6.81%
Accumulated Other Comprehensive Income (Loss), Net of Tax 226K USD
Retained Earnings (Accumulated Deficit) -795M USD -35.5%
Stockholders' Equity Attributable to Parent 481M USD +185%
Liabilities and Equity 615M USD +96.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -61.1M USD -45.6%
Net Cash Provided by (Used in) Financing Activities 1.47M USD -9.3%
Net Cash Provided by (Used in) Investing Activities 25.5M USD -28.1%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 76.2M shares +55.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -34.1M USD -608%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 76.8M USD +51.5%
Deferred Tax Assets, Valuation Allowance 227M USD +17.2%
Deferred Tax Assets, Gross 233M USD +15%
Operating Lease, Liability 28.3M USD -7.55%
Payments to Acquire Property, Plant, and Equipment 3.49M USD +20.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -208M USD -46.5%
Lessee, Operating Lease, Liability, to be Paid 38.5M USD -9.41%
Property, Plant and Equipment, Gross 55.2M USD +19.6%
Operating Lease, Liability, Current 6.64M USD -9.18%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.91M USD -36.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.24M USD +7.77%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10.1M USD -14.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.99M USD +2.71%
Deferred Tax Assets, Operating Loss Carryforwards 91.8M USD -0.37%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 21.9M USD +41%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.07M USD +2.71%
Operating Lease, Payments 2.15M USD +12.1%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 6.09M USD -31.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%